Voltar
Artigo Revisado por pares
BIBTEX RIS

Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial

2011; Springer Science+Business Media; Volume: 130; Issue: 1 Linguagem: Inglês

10.1007/s10549-011-1695-8

ISSN

1573-7217

Autores

Ian Smith, Jean‐Yves Pierga, Laura Biganzoli, H. Cortés-Funes, Christoph Thomssen, Silvana Saracchini, Bella Nisenbaum, Ignacio Peláez, Anja-Alexandra Duenne, Kathleen I. Pritchard,

Tópico(s)

Colorectal Cancer Treatments and Studies

Referência(s)